As a surgical oncologist, Dr. Kizy specializes in the surgical care of cancer patients. He works as a part of a multidisciplinary care team devoted to the treatment and cure of cancer. Being an oncology provider, Dr. Kizy values the long lasting relationships with patients and their family. He feels it is an honor to be a part of a patient's journey during this challenging time. Additionally, Dr. Kizy is passionate about delivering high-quality, evidence-based, multidisciplinary cancer care to all patients. He pledges to care for all patients as if they were his own family. During his career, Dr. Kizy's primary research interests focused on understanding the biology of cancer cachexia. He has also studied the effects of gut bacteria on surgical outcomes and health. Lastly, he has experience studying cancer and surgery outcomes utilizing large datasets.
Nearly 153 thousand Americans will learn they have colorectal cancer in 2024, according to the American Cancer Society (ACS). The ACS estimates more than 53 thousand will die this year, making it the third most common cause of cancer deaths. As is the case with most types of cancer, catching it early can make a life-or-death difference. “Finding it at an earlier stage allows the cancer to be immensely more curable,” said Karmanos Cancer Institute at McLaren Flint Surgical Oncologist Dr. Scot...
ABC12 Scott Kizy, M.D. , surgical oncologist at the Karmanos Cancer Institute at McLaren Flint and Clarkston , joined Good Morning Mid-Michigan and discussed colorectal cancer. He covered who may be at a higher risk of developing the disease, who should get a colonoscopy, and symptoms not to ignore. Dr. Kizy is also a member of Karmanos’ Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team . Watch here .